Children make up 25% of the UK population and care encompasses normal and abnormal growth and development, acute infectious disease, rare inherited disorders, and chronic disorders shared by the adult population.
Foetal development is dependent upon genetics, epigenetics and various other maternal influences, both in health and disease. In-utero growth and development effect long-term outcome in childhood and adult life through prenatal programming. Prematurity and foetal disease increases risks to children. Added to this, we are in the midst of a global epidemic of obesity and diabetes affecting both adults and children.
Cancer affects 1 in 3 of us, and rather than being purely genetic, hormones influence tumour growth. There are also more than 6,000 rare diseases, most of which are inherited disorders.
Endocrine research at the University of Birmingham addresses the role of hormones in obesity, diabetes, cancer, infertility and many other conditions to find new diagnostic tools and treatments that will make a difference, focused within the Centre for Endocrinology, Diabetes & Metabolism (CEDAM). There are also a plethora of research areas around reproduction and women’s health from the laboratory to clinical trials, a wider collaborative effort formalised through the Centre for Women & Children’s Health.
Our research adopts a truly translational bench-to-bedside and bedside-to-bench approach. We use state-of-the-art molecular and cell biology techniques through to rodent models and the highest quality cutting edge metabolic research in patients. We use unparalleled clinical research facilities which lie immediately adjacent to our basic science laboratories, the Queen Elizabeth Hospital and Birmingham Women’s Hospital, all immediately co-located.